Shanghai MicroPort MedBot Group Receives Over 100 Toumai Surgical Robot Orders Worldwide
Shanghai MicroPort MedBot Group Co. Ltd. announced that its cumulative order volume for laparoscopic, orthopedic, and vascular interventional core products has exceeded 170 units, according to preliminary internal statistics. The company's core product, the Toumai Laparoscopic Surgical Robot, has received over 100 commercial orders worldwide, with nearly 80 installations. The company also reported that Toumai has completed commercial deployment at one of the world's top two leading medical institutions, implementing both single-port and multi-port series. The information provided is unaudited and based on preliminary internal data.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai MicroPort MedBot Group Co. Ltd. published the original content used to generate this news brief on October 08, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。